Correction: ER(+) Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Những quyển sách tương tự

• ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors
  Bằng: Guerrero-Zotano, Angel L., et al.
  Được phát hành: (2018)
• A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
  Bằng: Garcia-Casado, Zaida, et al.
  Được phát hành: (2010)
• The role of CDK4/6 inhibitors in early breast cancer
  Bằng: Gil-Gil, Miguel, et al.
  Được phát hành: (2021)
• A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
  Bằng: Aphinives, Potchavit, et al.
  Được phát hành: (2015)
• The early days of letrozole
  Bằng: Bhatnagar, Ajay S.
  Được phát hành: (2007)